Co-Diagnostics, Inc. - 8-K Filing

Co-Diagnostics collaborates with ReadyGo Diagnostics to evaluate blood-based molecular testing for Ebola and other pathogens using the Co-Dx PCR platform. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $CODX

Read the full article at SEC EDGAR

More Regulatory news